Feedback on Neogenomics' Stock Report
Investment Banker:The research report on NGNM is wonderful. You guys did a great job, and as a first run I am very impressed. Congratulations to you and your analyst.
Institutional Investor, Biotechnology:
I read your first report. It is one of the best I have seen, and the best for a micro cap issue. You are on to something here. I know of no other group in the country doing this quality of work for a small cap issue.
Of course, this is what I have come to expect from the Hawk Group, so it was no real surprise to me.
Great work!!!!!!!!
CEO, Biotechnology:
A quick review reveals an impressive effort. I will enjoy
looking at this more closely.